Related Experiment Video
Updated: Apr 22, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Spatial profiling of chronic liver disease: a pilot spatial case series
Shota Sasagawa1, Atsushi Ono2, Koji Arihiro3
1Laboratory for Cancer Genomics, RIKEN Center for Integrative Medical Sciences, Yokohama, 230-0045, Japan.
Chronic liver disease tissues share a common spatial organization, with specific immune, metabolic, and viral programs varying by cause, such as alcohol-associated liver disease (ALD) and metabolic dysfunction-associated steatohepatitis (MASH). This spatial architecture offers new insights into liver disease progression.
Area of Science:
- Hepatology
- Molecular Biology
- Genomics
Background:
- The spatial organization of chronic liver disease (CLD) across different causes is not fully understood.
- Investigating CLD spatial architecture can reveal disease mechanisms and therapeutic targets.
Purpose of the Study:
- To explore the spatial transcriptomic landscape of alcohol-associated liver disease (ALD), metabolic dysfunction-associated steatohepatitis (MASH), and chronic hepatitis C (HCV).
- To identify shared and distinct spatial features and cell-cell communication patterns in CLD.
Main Methods:
- Sequencing-based spatial transcriptomics applied to human liver tissues.
- Viral-aware workflow for in situ detection of viral RNA.
- Histology-guided niche annotation and cell-cell communication analysis.
Main Results:
- Viral RNA in HCV cases localized to immune-enriched areas and pathways involved in cell-cycle and immune checkpoints.
- Histology-guided segmentation aligned with transcriptomic clusters in ALD and MASH.
- Recurrent functional compartments and immune-mesenchymal signaling hubs were identified across etiologies.
Conclusions:
- Chronic liver disease tissues exhibit a shared pseudolobular functional architecture.
- Etiology-specific programs (immune, metabolic, viral) are superimposed on this architecture.
- Spatial transcriptomics provides a powerful tool for dissecting CLD heterogeneity.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Gross Anatomy of the Liver
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
Cirrhosis II: Pathophysiology

